Market Cap: $380.77M
Market Cap: $380.77M
Open
$32.39
Prev. Close
$22.95
High
$32.97
Low
$30.68
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses.
Claritev Corporation trades on the New York Stock Exchange under the ticker CTEV, priced in USD.
Claritev Corporation has a market capitalisation of $380.77M, based on its latest share price.
CTEV has no meaningful P/E ratio because it reported a loss over the last 12 months.
Over the past 52 weeks CTEV has traded between $11.50 and $55.50.
No. Claritev Corporation does not currently pay a dividend.
Loss-making over the last 12 months (net margin -27.1%).
The analyst consensus rating for CTEV is Buy. Analysts' average 12-month price target of $42.56 implies 91% upside.
Travis S. Dalton is the CEO of Claritev Corporation, which is headquartered in McLean.
Generated automatically from reported financial data. General information only, not financial advice.